Condition or disease | Intervention/treatment |
---|---|
Stroke | Procedure: Acupuncture |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 1500 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 6 Months |
Official Title: | The Establishment and Analysis of the Clinical Prediction Model of Acupuncture and Moxibustion for Stroke Recovery |
Estimated Study Start Date : | June 1, 2019 |
Estimated Primary Completion Date : | December 31, 2019 |
Estimated Study Completion Date : | March 31, 2020 |
Group/Cohort | Intervention/treatment |
---|---|
Acupuncture group
Using acupuncture, electric acupuncture, moxibustion and acupoint injection treatment.
|
Procedure: Acupuncture
Using acupuncture, electric acupuncture, moxibustion and acupoint injection treatment.
|
Basic treatment group
Use basic treatments, such as western medicine.
|
Procedure: Acupuncture
Using acupuncture, electric acupuncture, moxibustion and acupoint injection treatment.
|
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Contact: Huiting Yang, Bachelor | +86 15757125322 | momoyiyi123456@163.com |
China, Zhejiang | |
The Third Affiliated Hospital of Zhejiang Chinese Medical University | Recruiting |
Hangzhou, Zhejiang, China, 310000 | |
Contact: Huiting Yang, Bachelor +86 15757125322 momoyiyi123456@163.com |
Study Director: | Ruijie Ma, Doctor | The Third Affiliated hospital of Zhejiang Chinese Medical University |
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | May 7, 2019 | ||||
First Posted Date | May 10, 2019 | ||||
Last Update Posted Date | May 14, 2019 | ||||
Estimated Study Start Date | June 1, 2019 | ||||
Estimated Primary Completion Date | December 31, 2019 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
Clinical Neurological Functional Impairment Assessment for Stroke Patients [ Time Frame: Change from neurological functional impairment score at 6 months(or the last discharge time ,which less than 6 months) ] To evaluate the consciousness, muscle power, dysarthria, sensory disturbancen and ataxia of stroke patients on the first day, the seventh day, the fifteenth day, the first month and the sixth month after admission (or the last time of discharge).The total score is 0-29 points. The lower the score, the less the neurological defect. The efficacy will be assessed as an improvement in the neurological functional impairment score (eg, score improvement = score at admission - score at discharge), and treatment was effective when the score was reduced by more than 18%.
|
||||
Original Primary Outcome Measures |
Neurological impairment score [ Time Frame: Change from neurological impairment score at 6 months(or the last discharge time ,which less than 6 months) ] To evaluate the consciousness, muscle strength, movement, sensation and mutual assistance of stroke patients on the first day, the seventh day, the fifteenth day, the first month and the sixth month after admission (or the last time of discharge)
|
||||
Change History | |||||
Current Secondary Outcome Measures | Not Provided | ||||
Original Secondary Outcome Measures | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | The Establishment and Analysis of the Clinical Prediction Model of Acupuncture and Moxibustion for Stroke Recovery | ||||
Official Title | The Establishment and Analysis of the Clinical Prediction Model of Acupuncture and Moxibustion for Stroke Recovery | ||||
Brief Summary | Electronic health records of stroke convalescent patients will be selected from the third affiliated hospital of Zhejiang Chinese Medical University from January 2012 to December 2019. Relevant clinical data will be extracted according to case data, and model-based decision tree analysis will be conducted to establish and evaluate the clinical prediction Model. | ||||
Detailed Description | Cases will be screened according to inclusion and exclusion criteria.Patients' basic information, risk factors, types of stroke, TCM diagnosis, all treatment during hospitalization, neurological impairment evaluation, imaging examination results and other contents will be recorded.Finally, statistical processing will be carried out to establish the prediction model, draw ROC curve and evaluate the model. | ||||
Study Type | Observational [Patient Registry] | ||||
Study Design | Observational Model: Other Time Perspective: Prospective |
||||
Target Follow-Up Duration | 6 Months | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Probability Sample | ||||
Study Population | The study population will be stroke convalescent patients from The Third Affiliated Hospital of Zhejiang Chinese Medical University from January 2012 to December 2019. | ||||
Condition | Stroke | ||||
Intervention | Procedure: Acupuncture
Using acupuncture, electric acupuncture, moxibustion and acupoint injection treatment.
|
||||
Study Groups/Cohorts |
|
||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Unknown status | ||||
Estimated Enrollment |
1500 | ||||
Original Estimated Enrollment | Same as current | ||||
Estimated Study Completion Date | March 31, 2020 | ||||
Estimated Primary Completion Date | December 31, 2019 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | 18 Years and older (Adult, Older Adult) | ||||
Accepts Healthy Volunteers | No | ||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries | China | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT03946566 | ||||
Other Study ID Numbers | MRJ-HT-1001 | ||||
Has Data Monitoring Committee | Not Provided | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement | Not Provided | ||||
Responsible Party | Yang Huiting, The Third Affiliated hospital of Zhejiang Chinese Medical University | ||||
Study Sponsor | The Third Affiliated hospital of Zhejiang Chinese Medical University | ||||
Collaborators | Not Provided | ||||
Investigators |
|
||||
PRS Account | The Third Affiliated hospital of Zhejiang Chinese Medical University | ||||
Verification Date | May 2019 |